P/E Ratio (TTM)
-24.72
Abivax S.A. currently has a P/E ratio of -24.72. The P/E ratio is a primary valuation multiple used to determine if a stock is overvalued or undervalued relative to its earnings.
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2013-06-30 | -0.01 |
| 2013-12-31 | -0.01 |
| 2014-06-30 | -65.07 |
| 2014-12-31 | -9.81 |
| 2015-06-30 | -6.81 |
| 2015-12-31 | -3.96 |
| 2016-06-30 | -1.34 |
| 2016-12-31 | -2.56 |
| 2017-06-30 | -5.69 |
| 2017-12-31 | -3.86 |
| 2018-06-30 | -2.36 |
| 2018-12-31 | -3.60 |
| 2019-06-30 | -1.38 |
| 2019-12-31 | -4.17 |
| 2020-06-30 | -4.12 |
| 2020-12-31 | -5.56 |
| 2021-06-30 | -6.55 |
| 2021-12-31 | -4.82 |
| 2022-06-30 | -1.48 |
| 2022-12-31 | -0.82 |
| 2023-06-30 | -2.70 |
| 2023-12-31 | -1.29 |
| 2024-06-30 | -2.47 |
| 2024-12-31 | -1.13 |
| 2025-06-30 | -1.04 |
Annual P/E
| Year | P/E Ratio |
|---|
* P/E ratios are calculated using trailing twelve-month (TTM) earnings. Extreme values may indicate earnings anomalies or cyclical volatility.